脑出血患者阿片类药物使用风险因素
该单中心回顾性队列纳入468例非创伤性脑出血患者,排除死亡及接受临终关怀者,以多因素回归校正病前阿片使用后分析住院及出院阿片使用的风险因素。住院期间53%(n=248)使用阿片类药物,出院时12%(n=53)带药;住院使用与较年轻(多因素OR 0.96/岁,95%CI 0.94-0.98)、较大血肿体积(OR 1.05/cm³,95%CI 1.03-1.08)及幕下、脑室出血、血管病变等相关。出院带药风险因素包括血管病变、恶性肿瘤、血管病及继发病因;出院带药者43%在出院3个月时仍续配。作者认为住院阿片使用常见,但出院带药比例低,提示住院使用未必导致高比例长期依赖。
要点
- 住院期间53%(248/468)使用阿片类药物,最常用为芬太尼38%、羟考酮30%、吗啡26%、氢吗啡酮7%。
- 所有行脑室外引流及开颅/去骨瓣减压的患者均接受了住院阿片治疗。
- 住院阿片使用与较年轻(多因素OR 0.96/岁,95%CI 0.94-0.98)及较大血肿体积(OR 1.05/cm³,95%CI 1.03-1.08)独立相关。
- 出院时12%(53/468)带阿片处方,其中43%(23/53)在出院3个月时仍续配。
- 幕下出血(OR 4.8,95%CI 2.3-10.0)、脑室出血(OR 3.9,95%CI 2.2-7.0)及继发病因增加住院阿片使用风险。
适用人群与场景
- 单中心非创伤性脑出血患者,排除死亡或接受临终关怀者。
研究设计与关键结果
- 单中心回顾性队列,468例脑出血患者,15%(70例)病前使用阿片,53%(248例)住院期间使用阿片,12%(53例)出院带阿片处方。
- 住院最常用阿片:芬太尼38%、羟考酮30%、吗啡26%、氢吗啡酮7%。
- 住院阿片使用组较未使用组年轻(中位64[IQR 53.5-74] vs 76[67-83]岁,p<0.001;多因素OR 0.96/岁,95%CI 0.94-0.98),血肿体积更大(中位10.1[IQR 2.1-28.6] vs 2.7[0.8-9.9] cm³,p<0.001;多因素OR 1.05/cm³,95%CI 1.03-1.08)。
- 所有行脑室外引流及开颅/去骨瓣减压的患者均接受住院阿片治疗。
- 住院阿片使用其他风险因素:幕下位置OR 4.8(95%CI 2.3-10.0)、脑室出血OR 3.9(95%CI 2.2-7.0)、血管病变OR 3.0(95%CI 1.1-8.1)、其他继发病因OR 7.5(95%CI 1.7-32.8)。
- 出院带阿片风险因素:血管病变OR 4.0(95%CI 1.3-12.5)、恶性肿瘤OR 5.0(95%CI 1.5-16.4)、血管病OR 10.0(95%CI 1.8-54.2)、其他继发病因OR 7.2(95%CI 1.8-29.9)。
- 出院带药者中43%(23/53)在出院3个月时仍续配阿片处方。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为住院阿片使用常见,部分风险因素可能与原发性头痛病理生理机制相关;出院时阿片处方频率较低,提示住院阿片使用未必导致脑出血患者高比例长期阿片依赖。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Headache is a common presenting symptom of intracerebral hemorrhage (ICH) and often necessitates treatment with opioid medications. However, opioid prescribing patterns in patients with ICH are not well described. We aimed to characterize the prevalence and risk factors for short and longer-term opioid use in patients with ICH.
METHODS: We conducted a retrospective cohort study using data from a single-center registry of patients with nontraumatic ICH. This registry included data on demographics, ICH-related characteristics, and premorbid, inpatient, and postdischarge medications. After excluding patients who died or received end-of-life care, we used multivariable regression models adjusted for premorbid opioid use to determine demographic and ICH-related risk factors for inpatient and postdischarge opioid use.
RESULTS: Of 468 patients with ICH in our cohort, 15% (n = 70) had premorbid opioid use, 53% (n = 248) received opioids during hospitalization, and 12% (n = 53) were prescribed opioids at discharge. The most commonly used opioids during hospitalization were fentanyl (38%), oxycodone (30%), morphine (26%), and hydromorphone (7%). Patients who received opioids during hospitalization were younger (univariate: median [interquartile range] 64 [53.5-74] vs. 76 [67-83] years, p < 0.001; multivariable: odds ratio [OR] 0.96 per year, 95% confidence interval [CI] 0.94-0.98) and had larger ICH volumes (univariate: median [interquartile range] 10.1 [2.1-28.6] vs. 2.7 [0.8-9.9] cm3, p < 0.001; multivariable: OR 1.05 per cm3, 95% CI 1.03-1.08) than those who did not receive opioids. All patients who had external ventricular drain placement and craniotomy/craniectomy received inpatient opioids. Additional risk factors for increased inpatient opioid use included infratentorial ICH location (OR 4.8, 95% CI 2.3-10.0), presence of intraventricular hemorrhage (OR 3.9, 95% CI 2.2-7.0), underlying vascular lesions (OR 3.0, 95% CI 1.1-8.1), and other secondary ICH etiologies (OR 7.5, 95% CI 1.7-32.8). Vascular lesions (OR 4.0, 95% CI 1.3-12.5), malignancy (OR 5.0, 95% CI 1.5-16.4), vasculopathy (OR 10.0, 95% CI 1.8-54.2), and other secondary etiologies (OR 7.2, 95% CI 1.8-29.9) were also risk factors for increased opioid prescriptions at discharge. Among patients who received opioid prescriptions at discharge, 43% (23 of 53) continued to refill their prescriptions at 3 months post discharge.
CONCLUSIONS: Inpatient opioid use in patients with ICH is common, with some risk factors that may be mechanistically connected to primary headache pathophysiology. However, the lower frequency of opioid prescriptions at discharge suggests that inpatient opioid use does not necessarily lead to a high rate of long-term opioid dependence in patients with ICH.
参考来源
- Lin N, Mandel D, Chuck CC, et al. Risk Factors for Opioid Utilization in Patients with Intracerebral Hemorrhage. Neurocrit Care. 2021. PMID: 34931281. doi:10.1007/s12028-021-01404-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。